Certara

@Certara

Certara is the global leader in advancing modern, efficient drug development.

Princeton, NJ (Headquarters)
Vrijeme pridruživanja: studeni 2011.

Medijski sadržaj

  1. prije 9 sati

    On Thursday, February 13th be sure to join our with a live Q&A session to learn how you should prepare to assess price and value through emerging assessments and novel frameworks. Register here:

  2. prije 12 sati

    Our 2019 best of the blog book is your guide to the industry’s latest trends in modeling and simulation (M&S), regulatory science, and real-world value assessment. Download it here:

  3. 5. velj

    Certara is dedicated to supporting safer and more effective cancer drugs.

  4. 4. velj

    Certara is dedicated to supporting safer and more effective cancer drugs.

  5. 3. velj

    - Last week we provided a webinar that gave an overview of the major additions to the Simulator’s ADAM and M-ADAM models. Watch it here:

  6. 2. velj

    Looking for a new opportunity? Click here to explore some of our latest hot :

  7. 1. velj

    Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here:

  8. 1. velj

    Certara is hiring an Associate Scientist within our Strategic Consulting division! This position will be based in - Learn more:

  9. 31. sij

    - Demonstrating bioequivalence (BE) with Certara’s Simcyp MechDermA Model. Read here:

  10. 30. sij

    Join our new 3-day classroom course that teaches students to go beyond NCA! Learn to model and simulate individual and population data. Session coming up 24-26 March 2020 in . To learn more and register, visit

  11. 28. sij

    Don't miss out on our first webinar of 2020! Tomorrow we will present, "Updates to the Simcyp Simulator’s Oral Absorption ADAM and M-ADAM Models." Register now:

  12. 27. sij

    [2/13 Webinar] We'll discuss how pricing has evolved from the 1990s to today for the rare disease drug market and much more! Register here:

  13. 24. sij

    Certara University is offering LIVE online classroom course focused on learning Noncompartmental analysis (NCA) using Phoenix WinNonlin. To learn more and register, visit

  14. 23. sij

    Free! A compilation of Certara’s biggest challenges and accomplishments in model-informed drug development, health economics/outcomes research and real world evidence, and regulatory science, strategy, and services. To download the blog book, visit

  15. 23. sij

    - More than 90% of novel new drug approvals by the US Food and Drug Administration () in 2019 were supported by Certara or services. To read the full press release, visit

  16. 22. sij

    [1/29 Webinar] Learn about recent additions to the ADAM/M-ADAM mechanistic models in version 19 of the Simcyp Population-based PBPK Simulator. Register here:

  17. 17. sij

    This week's post discusses strategies for supporting value-based drug pricing! Read it here:

  18. 13. sij

    Meet with some of Certara’s subject matter experts at ! We're excited to be here and showcase how Certara is changing the game in drug development and patient access. To learn more about us, visit

  19. 11. sij

    Join the Certara team! We have exciting opportunities to work with hundreds of biopharmaceutical companies, leading academic institutions, and key regulatory agencies worldwide! Find a position that fits you here:

  20. 10. sij

    - Guest writer Leticia Arrington from Merck explores how utilizing model-based meta-analysis () methodologies can support the future development of novel drugs to treat DPN, PHN, and fibromyalgia. Read here:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·